Cyclin-dependent kinase 4 inhibits the translational repressor 4E-BP1 to promote cap-dependent translation during mitosis-G1 transition

被引:5
作者
Mitchell, Dylan C. [1 ]
Menon, Arya [2 ]
Garner, Amanda L. [1 ,2 ]
机构
[1] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA
关键词
4E-BP1; cap-dependent translation; CDK4; mitosis; INITIATION-FACTOR EIF-4E; MESSENGER-RNA; CELL-CYCLE; BINDING-PROTEIN; COMPUTATIONAL PLATFORM; CDK4/6; INHIBITORS; BREAST-CANCER; MTOR KINASE; PHOSPHORYLATION; EIF4E;
D O I
10.1002/1873-3468.13721
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation of translational repressor eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) controls the initiation of cap-dependent translation, a type of protein synthesis that is frequently upregulated in human diseases such as cancer. Because of its critical cellular function, it is not surprising that multiple kinases can post-translationally modify 4E-BP1 to drive aberrant cap-dependent translation. We recently reported a site-selective chemoproteomic method for uncovering kinase-substrate interactions, and using this approach, we discovered the cyclin-dependent kinase (CDK)4 as a new 4E-BP1 kinase. Herein, we describe our extension of this work and reveal the role of CDK4 in modulating 4E-BP1 activity in the transition from mitosis to G1, thereby demonstrating a novel role for this kinase in cell cycle regulation.
引用
收藏
页码:1307 / 1318
页数:12
相关论文
共 70 条
[1]   A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells [J].
Anders, Lars ;
Ke, Nan ;
Hydbring, Per ;
Choi, Yoon J. ;
Widlund, Hans R. ;
Chick, Joel M. ;
Zhai, Huili ;
Vidal, Marc ;
Gygi, Stephen P. ;
Braun, Pascal ;
Sicinski, Piotr .
CANCER CELL, 2011, 20 (05) :620-634
[2]  
BATES S, 1994, ONCOGENE, V9, P1633
[3]   Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique [J].
Batool, Asiya ;
Aashaq, Sabreena ;
Andrabi, Khurshid Iqbal .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2017, 96 (04) :325-336
[4]  
BONNEAU AM, 1987, J BIOL CHEM, V262, P11134
[5]   Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin [J].
Brunn, GJ ;
Hudson, CC ;
Sekulic, A ;
Williams, JM ;
Hosoi, H ;
Houghton, PJ ;
Lawrence, JC ;
Abraham, RT .
SCIENCE, 1997, 277 (5322) :99-101
[6]   Inhibition of S/G2 phase CDK4 reduces mitotic fidelity [J].
Burgess, A ;
Wigan, M ;
Giles, N ;
DePinto, W ;
Gillespie, P ;
Stevens, F ;
Gabrielli, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :9987-9995
[7]   CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability [J].
Choi, Seung H. ;
Martinez, Thomas F. ;
Kim, Seongjae ;
Donaldson, Cynthia ;
Shokhirev, Maxim N. ;
Saghatelian, Alan ;
Jones, Katherine A. .
GENES & DEVELOPMENT, 2019, 33 (7-8) :418-435
[8]   Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation [J].
Choo, Andrew Y. ;
Yoon, Sang-Oh ;
Kim, Sang Gyun ;
Roux, Philippe P. ;
Blenis, John .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (45) :17414-17419
[9]   Not all substrates are treated equally Implications for mTOR, rapamycin-resistance and cancer therapy [J].
Choo, Andrew Y. ;
Blenis, John .
CELL CYCLE, 2009, 8 (04) :567-572
[10]   Phosphorylation of eIF4GII and 4E-BP1 in response to nocodazole treatment A reappraisal of translation initiation during mitosis [J].
Coldwell, Mark J. ;
Cowan, Joanne L. ;
Vlasak, Markete ;
Mead, Abbie ;
Willett, Mark ;
Perry, Lisa S. ;
Morley, Simon J. .
CELL CYCLE, 2013, 12 (23) :3615-3628